Silevimig

Approval Year

Name

Type

Language

Silevimig

Official Name

English

Immunoglobulin (G1_L-kappa)_scFv-G1(h-CH2-CH3), anti-[rabies lyssavirus (rabies virus, RABV) glycoprotein G epitope III] and anti-[rabies lyssavirus (rabies virus, RABV) glycoprotein G epitope I] Homo sapiens monoclonal antibody, bispecific

Common Name

English

Immunoglobulin, anti-(rabies virus spike glycoprotein G) (human clone S2E3 single-chain Fv fragment VH-(GGGGS)3-VL) fusion protein with immunoglobulin G1 [5-serine,134-cysteine,151-serine,153-alanine,192-valine] (human γ1-chain C region C-terminal fragm

Common Name

English

silevimig [INN]

Common Name

English

Code System Code Type Description

INN

12660

Created by admin on Sat Dec 16 20:00:59 GMT 2023 , Edited by admin on Sat Dec 16 20:00:59 GMT 2023

PRIMARY

FDA UNII

K3CR9VL7SE

Created by admin on Sat Dec 16 20:00:59 GMT 2023 , Edited by admin on Sat Dec 16 20:00:59 GMT 2023

PRIMARY

CAS

2618667-99-3

Created by admin on Sat Dec 16 20:00:59 GMT 2023 , Edited by admin on Sat Dec 16 20:00:59 GMT 2023

PRIMARY

ACTIVE MOIETY


					K3CR9VL7SE

Silevimig